Impact of pharmacodynamics on dosing schedules: Optimizing efficacy, reducing resistance, and detection of emergence of resistance

Antibiotic Policies: Theory and Practice

Volumn , Issue , 2005, Pages 387-407

  Mouton, Johan W ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889460597     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-22852-7_21     Document Type: Chapter

References (58)

1. Aeschlimann, J. R., Kaatz, G. W., and Rybak, M. J., 1999, J. Antimicrob. Chemother., 44, 343-349.
2. Ambrose, P. G. and Grasela, D. M., 2000, Diagn. Microbiol. Infect. Dis., 38, 151-157.
3. Ambrose, P. G., Grasela, D. M., Grasela, T. H., Passarell, J., Mayer, H. B., and Pierce, P. F., 2001, Antimicrob. Agents. Chemother., 45, 2793-2797.
4. Andes, D. and Craig, W. A., 2002, Int. J. Antimicrob. Agents., 19, 261-268.
5. Andes, D. R. and Craig, W. A., 1998, Clin. Infect. Dis., 27, 47-50.
6. Andrews, J. M., 2001, J. Antimicrob. Chemother, 48 (Suppl. 1), 5-16.
7. Bedos, J. P., Azoulay-Dupuis, E., Moine, P., Muffat-Joly, M., Veber, B., Pocidalo, J. J. et al., 1998a, J. Pharmacol. Exp. Ther, 286, 29-35.
8. Bedos, J. P., Rieux, V, Bauchet, J., Muffat-Joly, M., Carbon, C, and Azoulay-Dupuis, E., 1998b, Antimicrob. Agents. Chemother, 42, 862-867.
9. Bergan, T., Bruun, J. N., Digranes, A., Lingaas, E., Melby, K. K., and Sander, J., 1997, Scand. J. Infect. Dis. Suppl., 103, 1-36.
10. Bonate, P. L., 2001, Clin. pharmacokinet., 40, 15-22.
11. Cars, O., 1990, Scand. J. Infect. Dis. Suppl., 74, 23-33.
12. Croisier, D., Chavanet, P., Lequeu, C, Ahanou, A., Nierlich, A., Neuwirth, C. et al., 2002, J. Antimicrob. Chemother, 50, 349-360.
13. de Man, P., Goessens, W. H., Verbrugh, H. A., and Mouton, J. W., 1998, In European Congress Chemotherapy. Hamburg, p. 85.
14. Deutsches Institut fur Normung, 1990, Deutsches Institut fur Normung, Beuth Verlag.
15. Drlica, K., 2003, J. Antimicrob. Chemother, 52, 11-17.
16. Drusano, G L., D'Argenio, D. Z., Preston, S. L., Barone, C, Symonds, W., LaFon, S. et al., 2000, Antimicrob. Agents. Chemother, 44, 1655-1659.
17. Drusano, G L., Johnson, D. E., Rosen, M., and Standiford, H. C, 1993, Antimicrob. Agents. Chemother, 37, 483-490.
18. Drusano, G L., Preston, S. L., Hardalo, C, Hare, R., Banfield, C, Andes, D et al., 2001, Antimicrob. Agents. Chemother, 45, 13-22.
19. Ericsson, H. M. and Sherris, J. C, 1971, Acta Pathol. Microbiol. Scand. [B] Microbiol. Immunol., 217, 1-90.
20. Ernst, E. J., Klepser, M. E., Petzold, C. R., and Doern, G V, 2002, Pharmacotherapy, 22, 463-470
21. EUCAST, 2003.
22. Fernandez, J., Barrett, J. F, Licata, L., Amaratunga, D, and Frosco, M., 1999, Antimicrob Agents. Chemother, 43, 667-671.
23. Firsov, A. A., Vostrov, S. N., Lubenko, I. Y., Drlica, K., Portnoy, Y. A., and Zinner, S. H, 2003, Antimicrob. Agents. Chemother., 47', 1604-1613.
24. Forrest, A., Chodosh, S., Amantea, M. A., Collins, D A., and Schentag, J. J., 1997, J. Antimicrob. Chemother, 40(Suppl. A), 45-57.
25. Forrest, A., Nix, D E., Ballow, C. H., Goss, T. F, Birmingham, M. C, and Schentag, J. J., 1993, Antimicrob. Agents. Chemother., 37, 1073-1081.
26. Grohs, P., Houssaye, S., Aubert, A., Gutmann, L., and Varon, E., 2003, Antimicrob. Agents Chemother, 47, 3542-3547.
27. Highet, V S., Forrest, A., Ballow, C. H., and Schentag, J. J., 1999, J. Antimicrob. Chemother, 43 (Suppl. A), 55-63.
28. Kahlmeter, G, Brown, D F J., Goldstein, F. W., MacGowan, A. P., Mouton, J. W., Österlund, A. et al., 2003, J. Antimicrob. Chemother.
29. Lacy, M. K., Lu, W., Xu, X., Tessier, P. R., Nicolau, D. P., Quintiliani, R. et al., 1999, Antimicrob. Agents Chemother, 43, 672-677.
30. Lim, S., Bast, D, McGeer, A., de Azavedo, J., and Low, D E., 2003, Emerg. Infect. Dis., 9, 833-837.
31. Lister, P. D, 2002, Antimicrob. Agents Chemother, 46, 69-74.
32. Lister, P. D. and Sanders, C. C, 1999a, J. Antimicrob. Chemother., 43, 79-86.
33. Lister, P. D. and Sanders, C. C, 1999b, Antimicrob. Agents Chemother, 43, 1118-1123.
34. Liu, P., Muller, M., and Derendorf, H., 2002, Int. J. Antimicrob. Agents.
35. MacGowan, A. P. and Wise, R., 2001, J. Antimicrob. Chemother, 48(Suppl. 1), 17-28.
36. Madaras-Kelly, K. J., Ostergaard B. E., Hovde, L. B., and Rotschafer, J. C, 1996, Antimicrob. Agents. Chemother, 40, 627-632.
37. Mattoes, H. M., Banevicius, M., Li, D., Turley, C, Xuan, D., Nightingale, C. H. et al., 2001, Antimicrob. Agents. Chemother, 45, 2092-2097.
38. Montgomery, M. J., Beringer, P. M., Aminimanizani, A., Louie, S. G., Shapiro, B. J., Jelliffe, R. et al., 2001, Antimicrob. Agents. Chemother, 45, 3468-3473.
39. Mouton, J. W., 2002, Int. J. Antimicrob. Agents, 19, 323-331.
40. Mouton, J. W., 2003, Infect. Dis. Clin. North Am., 17, 579-598.
41. Mouton, J. W., Dudley, M. N, Cars, O., Derendorf, H., and Drusano, G L., 2002a, Int. J. Antimicrob. Agents, 19, 355-358.
42. Mouton, J. W., Horrevorts, A. M., Mulder, P. G, Prens, E. P. and Michel, M. F., 1990, Antimicrob. Agents Chemother., 34, 2307-2311.
43. Mouton, J. W. and Punt, N, 2001, J. Antimicrob. Chemother, 47, 500-501.
44. Mouton, J. W., Schmitt-Hoffmann, A., Shapiro, S., Nashed N. and Punt, N. C, 2004, Antimicrob. Agents Chemother., 48, 1713-1718.
45. Mouton, J. W., van Klingeren, B., de Neeling, A. J., Degener, J. E., and Commissie Richtlijnen Gevoeligheidsbepalingen, 2000, Nederlands Tijdschrift voor Medische Microbiologie, 8, 73-78.
46. NCCLS, 2002, Performance Standards for Antimicrobial Susceptibility Testing; Twelfth International Supplement. M100-S12 (M7). NCCLS, Wayne.
47. NCCLS 2003 www.nccls.org.
48. Ng, W, Lutsar, I., Wubbel, L., Ghaffar, F., Jafri, H., McCracken, G H. et al., 1999, J. Antimicrob. Chemother, 43, 811-816.
49. Nicolau, D. P. and Ambrose, P. G, 2001, Am. J. Med., 111(Suppl. 9A), 13S-18S; discussion 36S-38S.
50. Onyeji, C. O., Bui, K. Q., Owens, R. C, Jr., Nicolau, D P., Quintiliani, R., and Nightingale, C. H., 1999, Int. J. Antimicrob. Agents, 12, 107-114.
51. Peterson, M. L., Hovde, L. B., Wright, D. H., Hoang, A. D., Raddatz, J. K., Boysen, P. J. et al., 1999, Antimicrob. Agents Chemother, 43, 2251-2255.
52. Preston, S. L., Drusano, G L., Berman, A. L., Fowler, C. L., Chow, A. T., Dornseif, B. et al., 1998, J. Am. Med. Association, 279, 125-129.
53. Scaglione, F., Mouton, J. W, Mattina, R and Fraschini, F., 2003, Antimicrob. Agents Chemother., 47, 2749-2755.
54. Soussy, C. J., Cluzel, R, and Courvalin, P., 1994, Eur J. Clin. Microbiol. Infect. Dis., 13, 238-246.
55. Stearne, L. E., Lemmens, N, Goessens, W H. F., Mouton, J. W, and Gyssens, I. C, 2002, In European Conference Clinical Microbiology and Infectious Diseases. Milan. Swedish Reference Group of Antibiotics, 1997, Scandinavian J. Infect. Dis., 105S, 5-31.
56. Thomas, J. K., Forrest, A., Bhavnani, S. M., Hyatt, J. M., Cheng, A., Ballow, C. H. et al., 1998, Antimicrob. Agents. Chemother, 42, 521-527.
57. Turnidge, J., 1999, Drugs, 58(Suppl. 2), 29-36.
58. Zhao, X., and Drlica, K., 2002, J. Infect. Dis., 185, 561-565.